======= MICA ======= == Gene Information == * **Official Symbol**: MICA * **Official Name**: MHC class I polypeptide-related sequence A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=100507436|100507436]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q29983|Q29983]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MICA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MICA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600169|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the highly polymorphic major histocompatability complex class I chain-related protein A. The protein product is expressed on the cell surface, although unlike canonical class I molecules it does not seem to associate with beta-2-microglobulin. It is a ligand for the NKG2-D type II integral membrane protein receptor. The protein functions as a stress-induced antigen that is broadly recognized by intestinal epithelial gamma delta T cells. Variations in this gene have been associated with susceptibility to psoriasis 1 and psoriatic arthritis, and the shedding of MICA-related antibodies and ligands is involved in the progression from monoclonal gammopathy of undetermined significance to multiple myeloma. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2014]. * **UniProt Summary**: Seems to have no role in antigen presentation. Acts as a stress-induced self-antigen that is recognized by gamma delta T- cells. Ligand for the KLRK1/NKG2D receptor. Binding to KLRK1 leads to cell lysis. {ECO:0000269|PubMed:10426993, ECO:0000269|PubMed:11224526, ECO:0000269|PubMed:11491531, ECO:0000269|PubMed:11777960, ECO:0000269|PubMed:9497295}. |C1-set| |MHC I| |immune response to tumor cell| |gamma-delta T cell activation| |beta-2-microglobulin binding| |negative regulation of natural killer cell activation| |natural killer cell lectin-like receptor binding| |response to tumor cell| |susceptibility to natural killer cell mediated cytotoxicity| |negative regulation of natural killer cell mediated cytotoxicity| |negative regulation of natural killer cell mediated immunity| |T cell mediated cytotoxicity| |negative regulation of leukocyte mediated cytotoxicity| |negative regulation of cell killing| |cytolysis| |natural killer cell mediated cytotoxicity| |natural killer cell mediated immunity| |positive regulation of natural killer cell mediated cytotoxicity| |regulation of natural killer cell activation| |positive regulation of natural killer cell mediated immunity| |negative regulation of lymphocyte mediated immunity| |leukocyte mediated cytotoxicity| |T cell mediated immunity| |regulation of natural killer cell mediated cytotoxicity| |regulation of natural killer cell mediated immunity| |negative regulation of leukocyte mediated immunity| |positive regulation of leukocyte mediated cytotoxicity| |negative regulation of innate immune response| |natural killer cell activation| |positive regulation of cell killing| |regulation of leukocyte mediated cytotoxicity| |cell killing| |negative regulation of response to biotic stimulus| |regulation of cell killing| |positive regulation of lymphocyte mediated immunity| |response to heat| |negative regulation of immune effector process| |positive regulation of leukocyte mediated immunity| |negative regulation of lymphocyte activation| |negative regulation of immune response| |regulation of lymphocyte mediated immunity| |negative regulation of leukocyte activation| |response to temperature stimulus| |defense response to virus| |negative regulation of cell activation| |regulation of leukocyte mediated immunity| |negative regulation of defense response| |negative regulation of multi-organism process| |positive regulation of immune effector process| |T cell activation| |lymphocyte mediated immunity| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |response to virus| |defense response to bacterium| |positive regulation of innate immune response| |positive regulation of response to biotic stimulus| |negative regulation of response to external stimulus| |lymphocyte activation| |external side of plasma membrane| |negative regulation of immune system process| |regulation of innate immune response| |regulation of immune effector process| |positive regulation of defense response| |positive regulation of multi-organism process| |regulation of lymphocyte activation| |regulation of response to biotic stimulus| |positive regulation of response to external stimulus| |regulation of leukocyte activation| |adaptive immune response| |cell surface| |regulation of cell activation| |response to bacterium| |viral process| |regulation of defense response| |innate immune response| |leukocyte mediated immunity| |regulation of multi-organism process| |cellular response to DNA damage stimulus| |symbiotic process| |interspecies interaction between organisms| |positive regulation of immune response| |leukocyte activation| |defense response to other organism| |cell activation| |immune effector process| |regulation of response to external stimulus| |regulation of immune response| |positive regulation of immune system process| |response to abiotic stimulus| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |integral component of plasma membrane| |regulation of response to stress| |extracellular space| |negative regulation of response to stimulus| |regulation of immune system process| |cellular response to stress| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp283|Glyphosate 1000μM R06 exp283]]|1.72| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|2.03| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8786 * **Expression level (log2 read counts)**: 4.58 {{:chemogenomics:nalm6 dist.png?nolink |}}